ArticleStem cell research & therapy2026
Dexamethasone reduces osteogenic potential through suppressing retinoic acid signaling via NF-κB/CYP26B1 axis in mesenchymal stem cells.
Ai-Hua Ye et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.